GLP-1s: Real-Life Wonder Drugs?
US$ 27.33
carmot glp-1 How Receptor Agonists Evolved from Diabetes to Weight Loss Treatments Triple Agonism Based Therapies for
Description
Why the hype?
The business case
Story of game-changing obesity, diabetes therapy illustrates the crucial role of fundamental research breakthroughs.
Zepbound is a tirzepatide compoundnot semaglutidethat activates both GLP-1 and GIP receptors
Designed for once-monthly maintenance dosing
